Patience Pays Off For Kyowa Kirin As Nourianz Finally Gets US FDA OK

 
• By Mandy Jackson

The Japanese firm's original 2007 NDA was rejected in 2008 but it kept faith in the drug, now approved as an adjunct to levodopa/carbidopa. At least one competitor is waiting in the wings.

Parkinsons Disease
Nourianz is a levodopa/carbidopa add-on to treat "off" episodes. • Source: Shutterstock

More from New Products

More from Scrip